Publication

Knitter JR, Erly WK, Stea BD, Lemole GM, Germano IM, Doshi AH, Nael K. 2018. Interval Change in Diffusion and Perfusion MRI Parameters for the Assessment of Pseudoprogression in Cerebral Metastases Treated With Stereotactic Radiation. AJR Am J Roentgenol. 211:168–175. doi:10.2214/AJR.17.18890.

de la Vega MR, Chapman E, Zhang DD. 2018. NRF2 and the Hallmarks of Cancer. Cancer Cell. 34:21–43. doi:10.1016/j.ccell.2018.03.022.

Daenthanasanmak A, Wu Y, Iamsawat S, Nguyen HD, Bastian D, Zhang M, Sofi MH, Chatterjee S, Hill EG, Mehrotra S, et al. 2018. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J Clin Invest. 128:2787–2801. doi:10.1172/JCI95407.

Lin A, Kupinski MA, Peterson TE, Shokouhi S, Johnson LC. 2018. Task-based design of a synthetic-collimator SPECT system used for small animal imaging. Med Phys. 45:2952–2963. doi:10.1002/mp.12952.

Stewart DB, Gaertner WB, Glasgow SC, Herzig DO, Feingold D, Steele SR. 2018. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Anal Squamous Cell Cancers (Revised 2018). Dis Colon Rectum. 61:755–774. doi:10.1097/DCR.0000000000001114.

Wilkinson EM, Ilhan ZE, Herbst-Kralovetz MM. 2018. Microbiota-drug interactions: Impact on metabolism and efficacy of therapeutics. Maturitas. 112:53–63. doi:10.1016/j.maturitas.2018.03.012.

Calton CM, Kelly KR, Anwer F, Carew JS, Nawrocki ST. 2018. Oncolytic Viruses for Multiple Myeloma Therapy. Cancers (Basel). 10. doi:10.3390/cancers10060198.

Weinstein RS, Krupinski EA, Doarn CR. 2018. Clinical Examination Component of Telemedicine, Telehealth, mHealth, and Connected Health Medical Practices. Med Clin North Am. 102:533–544. doi:10.1016/j.mcna.2018.01.002.

Olek D, El-Ghamry MN, Deb N, Thawani N, Shaver C, Mutyala S. 2018. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-An analysis of 273 lesions. Brachytherapy. 17:601–608. doi:10.1016/j.brachy.2018.01.002.

LoConte NK, Gershenwald JE, Thomson CA, Crane TE, Harmon GE, Rechis R. 2018 May. Lifestyle Modifications and Policy Implications for Primary and Secondary Cancer Prevention: Diet, Exercise, Sun Safety, and Alcohol Reduction. Am Soc Clin Oncol Educ Book.:88–100. doi:10.1200/EDBK_200093.

Łaniewski P, Barnes D, Goulder A, Cui H, Roe DJ, Chase DM, Herbst-Kralovetz MM. 2018. Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women. Sci Rep. 8:7593. doi:10.1038/s41598-018-25879-7.

Sun V, Crane TE, Slack SD, Yung A, Wright S, Sentovich S, Melstrom K, Fakih M, Krouse RS, Thomson CA. 2018. Rationale, development, and design of the Altering Intake, Managing Symptoms (AIMS) dietary intervention for bowel dysfunction in rectal cancer survivors. Contemp Clin Trials. 68:61–66. doi:10.1016/j.cct.2018.03.010.

Mowlazadeh Haghighi S, Zhou Y, Dai J, Sawyer JR, Hruby VJ, Cai M. 2018. Replacement of Arg with Nle and modified D-Phe in the core sequence of MSHs, Ac-His-D-Phe-Arg-Trp-NH, leads to hMC1R selectivity and pigmentation. Eur J Med Chem. 151:815–823. doi:10.1016/j.ejmech.2018.04.021.

Mesko S, Marks L, Ragab O, Patel S, Margolis DA, Demanes DJ, Kamrava M. 2018. Targeted Prostate Biopsy Gleason Score Heterogeneity and Implications for Risk Stratification. Am J Clin Oncol. 41:497–501. doi:10.1097/COC.0000000000000308.

McLamarrah TA, Buster DW, Galletta BJ, Boese CJ, Ryniawec JM, Hollingsworth NA, Byrnes AE, Brownlee CW, Slep KC, Rusan NM, et al. 2018. An ordered pattern of Ana2 phosphorylation by Plk4 is required for centriole assembly. J Cell Biol. 217:1217–1231. doi:10.1083/jcb.201605106.

Thomson CA, Crane TE, Garcia DO, Wertheim BC, Hingle M, Snetselaar L, Datta M, Rohan T, LeBlanc E, Chlebowski RT, et al. 2018. Association between Dietary Energy Density and Obesity-Associated Cancer: Results from the Women’s Health Initiative. J Acad Nutr Diet. 118:617–626. doi:10.1016/j.jand.2017.06.010.

Barney CL, Walston S, Zamora P, Healy EH, Nolan N, Diavolitsis VM, Neki A, Rupert R, Savvides P, Agrawal A, et al. 2018. Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma. Oral Oncol. 79:9–14. doi:10.1016/j.oraloncology.2018.02.001.

Fang K, Dong G, Li Y, He S, Wu Y, Wu S, Wang W, Sheng C. 2018. Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase (HDAC) Dual Inhibitors. ACS Med Chem Lett. 9:312–317. doi:10.1021/acsmedchemlett.7b00487.

Henry-Noel N, Bishop M, Gwede CK, Petkova E, Szumacher E. 2018 Apr. Mentorship in Medicine and Other Health Professions. J Cancer Educ. doi:10.1007/s13187-018-1360-6.

Cromey B, McDaniel A, Matsunaga T, Vagner J, Kieu KQ, Banerjee B. 2018. Pancreatic cancer cell detection by targeted lipid microbubbles and multiphoton imaging. J Biomed Opt. 23:1–8. doi:10.1117/1.JBO.23.4.046501.

Garcia DO, Valdez LA, Bell ML, Humphrey K, Hingle M, McEwen M, Hooker SP. 2018. A gender- and culturally-sensitive weight loss intervention for Hispanic males: The ANIMO randomized controlled trial pilot study protocol and recruitment methods. Contemp Clin Trials Commun. 9:151–163. doi:10.1016/j.conctc.2018.01.010.

Wang H, Zhang Y, Yang H, Qin M, Ding X, Liu R, Jiang Y. 2018. In Vivo SELEX of an Inhibitory NSCLC-Specific RNA Aptamer from PEGylated RNA Library. Mol Ther Nucleic Acids. 10:187–198. doi:10.1016/j.omtn.2017.12.003.

Dodson M, Liu P, Jiang T, Ambrose AJ, Luo G, de la Vega MR, Cholanians AB, Wong PK, Chapman E, Zhang DD. 2018 Mar. Increased O-GlcNAcylation of SNAP29 drives arsenic-induced autophagic dysfunction. Mol Cell Biol. doi:10.1128/MCB.00595-17.

Gemma V, Mistrot D, Row D, Gagliano RA, Bremner RM, Walia R, Mehta AC, Panchabhai TS. 2018. Pneumatosis intestinalis in solid organ transplant recipients. J Thorac Dis. 10:1984–1997. doi:10.21037/jtd.2018.02.52.

Tavares ALP, Brown JA, Ulrich EC, Dvorak K, Runyan RB. 2018. Runx2-I is an Early Regulator of Epithelial-Mesenchymal Cell Transition in the Chick Embryo. Dev Dyn. 247:542–554. doi:10.1002/dvdy.24539.